Chief Medical Officer (CMO) – Rare Disease Biotech

Are you an accomplished medical leader with a passion for advancing groundbreaking therapies in rare and underserved diseases? We are seeking a Chief Medical Officer (CMO) to guide clinical strategy and scientific innovation for a rapidly growing biotech company in Cambridge, MA. This is a unique opportunity to shape the development of transformative medicines, lead clinical programs from early research through approval, and make a meaningful impact on patients with high unmet needs. If you excel in fast-paced, science-driven environments and have a proven track record in clinical development, this role is designed for you.

Lead Clinical and Scientific Strategy in a High-Growth Biotech Environment

A cutting-edge rare disease biotechnology company located in Cambridge, MA is searching for a visionary Chief Medical Officer (CMO) to drive its clinical programs and medical affairs initiatives. The ideal candidate will bring deep expertise in rare disease drug development, strong leadership capabilities, and the ability to collaborate closely with research, regulatory, and executive teams. If you are passionate about pioneering therapies, guiding clinical execution, and shaping the future of rare disease treatment, this is your opportunity to make a lasting difference in the biotech landscape.

Key Responsibilities of the Chief Medical Officer (CMO) – Rare Disease Biotech

Clinical Strategy & Vision

Develop and execute a forward-looking clinical strategy that aligns with the company’s mission to deliver transformative therapies for rare diseases. Provide medical leadership across all stages of clinical development, ensuring strategic alignment with scientific, regulatory, and commercial goals.

Clinical Development Leadership

Oversee the design, planning, and execution of clinical trials from early-stage development through pivotal studies. Ensure scientifically rigorous protocols, efficient trial operations, high-quality data generation, and adherence to timelines that support regulatory submissions and approvals.

Regulatory & Compliance Oversight

Partner closely with regulatory authorities to guide clinical programs and ensure full compliance with FDA, EMA, and global regulatory requirements. Prepare and review clinical sections of regulatory documents including INDs, NDAs, MAAs, and scientific briefing materials.

Cross-Functional Collaboration

Collaborate with research, regulatory, commercial, biostatistics, and operations teams to integrate clinical insights into broader corporate strategy. Provide medical expertise to cross-functional teams, ensuring alignment across R&D, clinical, and commercial functions.

Patient Safety & Pharmacovigilance

Establish and maintain robust safety monitoring processes for all clinical programs. Oversee benefit-risk assessments, adverse event reporting, and medical review activities to ensure patient safety and ethical clinical practices.

Scientific & Medical Affairs Leadership

Represent the company as its senior clinical voice at scientific conferences, advisory boards, and investor meetings. Build and lead medical affairs functions that support product launches, scientific education, and engagement with key opinion leaders (KOLs) in rare disease.

Portfolio & Pipeline Advancement

Identify opportunities to expand the clinical pipeline through strategic assessments, scientific evaluations, and partnerships. Support due diligence for licensing, collaborations, and acquisitions that enhance the company’s rare disease portfolio.

Team Leadership & Development

Build, mentor, and inspire a high-performing clinical development team. Foster a culture of scientific excellence, accountability, collaboration, and patient-centered innovation across all clinical functions.

Stakeholder & Investor Engagement

Communicate clinical program updates, data readouts, and strategic insights to investors, board members, and external partners. Provide clear, data-driven perspectives that enhance trust and support ongoing investment in the company’s mission.

Risk Management & Quality Oversight

Implement strong clinical governance, risk mitigation strategies, and quality control processes across all clinical programs. Ensure ethical conduct of research, protocol compliance, and protection of patient rights throughout development.

What the Client is Looking for in You

As the Chief Medical Officer – Rare Disease Biotech, the client seeks a visionary clinical leader with deep expertise in rare disease drug development and a passion for advancing breakthrough therapies. You should be an innovative, mission-driven medical executive who excels in complex clinical environments and can deliver strategic direction while maintaining top-tier scientific and operational standards.

Proven Leadership in Rare Disease & Biotech

The client is looking for an accomplished medical executive with extensive experience leading clinical programs in rare or ultra-rare diseases. You should have a history of guiding therapies from early-phase studies through regulatory approval, managing complex trials, and working closely with global health authorities. Experience with genetic, metabolic, neurological, or immunologic rare diseases is highly valued.

Strategic Thinker with a Patient-Driven Vision

You must be able to craft and execute clinical strategies that align with scientific innovation and patient needs. The ideal candidate can anticipate scientific trends, navigate clinical complexities, and adapt to rapidly evolving biotech environments. The client values leaders who balance innovation with operational discipline.

Strong Clinical, Regulatory & Medical Expertise

A deep understanding of clinical trial design, regulatory pathways, patient safety, and medical governance is essential. You should be confident leading interactions with the FDA, EMA, and global agencies while ensuring clinical excellence and regulatory compliance across all programs.

Ability to Lead and Inspire Clinical Teams

Leadership is core to this role, and the client is seeking a CMO who can build, develop, and retain a world-class clinical development organization. You should foster a culture of collaboration, scientific rigor, and accountability, ensuring teams remain aligned and motivated.

Scientific Credibility & External Engagement

You should have the ability to represent the company as a respected scientific leader among investigators, KOLs, advisory boards, and patient advocacy groups. Strong communication skills and the ability to translate complex data into compelling narratives are essential.

Strong Stakeholder & Investor Communication

The client seeks a CMO comfortable engaging with investors, board members, and strategic partners. Your ability to communicate medical insights, clinical progress, and data-driven recommendations will be crucial for maintaining strong relationships and securing long-term support.

Commitment to Patient Safety & Ethical Research

Finally, the ideal candidate demonstrates unwavering dedication to patient safety, ethical clinical development, and advancing therapies that address critical unmet needs in rare disease communities.

FAQs About the Role – Chief Medical Officer (CMO) – Rare Disease Biotech

1. What are the key responsibilities of the CMO in this role?

As Chief Medical Officer, you will lead the company’s clinical strategy, oversee clinical trial development, ensure regulatory compliance, and drive scientific and medical leadership across the organization. You will guide clinical programs from early development through regulatory milestones, ensure patient safety, build high-performing clinical teams, and serve as the company’s senior medical representative to stakeholders, key opinion leaders, and investors.

2. What qualifications and experience are required for this position?

The ideal candidate will have extensive experience in clinical development within biotechnology or pharmaceutical settings, preferably focused on rare or orphan diseases. Strong expertise in clinical trial design, regulatory interactions, and medical governance is essential. An M.D. or M.D./Ph.D. is required, along with a proven track record of advancing therapies through clinical stages and leading cross-functional teams.

3. What leadership qualities are essential for this role?

The client seeks a strategic, mission-driven leader with strong decision-making skills, excellent communication abilities, scientific credibility, and the capacity to inspire teams. The ideal CMO demonstrates strategic thinking, adaptability, a patient-centered mindset, and the ability to foster collaboration across clinical and scientific groups.

4. What challenges can I expect in this role?

Challenges may include navigating complex rare disease patient populations, managing small or global clinical trial networks, meeting regulatory expectations, and balancing scientific innovation with operational constraints. Ensuring patient safety, maintaining trial integrity, and achieving accelerated development timelines are central challenges of this role.

5. What is the expected impact of the CMO on the company’s growth?

The CMO will play a critical role in advancing the pipeline, achieving regulatory milestones, enhancing scientific reputation, and positioning the company as a leader in rare disease therapeutics. Your strategic direction and clinical leadership will directly influence development success, investor confidence, and overall company valuation.

6. What is the company’s culture and work environment like?

The company promotes a collaborative, science-driven, and patient-focused culture. They value leaders who encourage transparency, innovation, teamwork, and high ethical standards. As CMO, you will help strengthen this culture while contributing to a shared mission of improving the lives of patients with rare diseases.

What Remuneration Can You Expect from This Job?

As the Chief Medical Officer (CMO) – Rare Disease Biotech in Cambridge, MA, you can expect a highly competitive and comprehensive executive compensation package designed to attract top medical and clinical leadership talent within the biotechnology sector. Compensation for this role typically includes:

1. Base Salary

The base salary for a Chief Medical Officer in the biotech and rare disease sector varies based on company size, funding stage, and pipeline maturity. For a high-growth biotech in Cambridge, MA, annual base salaries typically range from $300,000 to $500,000, with well-funded or publicly traded companies often offering higher compensation.

2. Performance-Based Bonuses

CMOs generally receive annual performance bonuses tied to key clinical and strategic milestones such as trial progression, regulatory achievements, successful data readouts, and organizational development. Bonus structures can range from 25% to 75% of the base salary, depending on company performance and individual contributions.

3. Equity & Stock Options

Biotech companies—especially those in rare disease—commonly offer substantial equity incentives, including stock options, RSUs, or performance shares. These equity components can represent a significant portion of total compensation and are designed to align leadership incentives with long-term company growth, valuation milestones, and patient impact.

4. Long-Term Incentive Plans (LTIPs)

Many biotech firms provide long-term incentive plans tied to multi-year objectives such as clinical program advancement, successful regulatory approvals, or commercialization milestones. LTIPs help ensure strategic alignment and may include additional equity grants, milestone payments, or bonus incentives.

5. Executive Benefits & Perks

CMOs can expect a robust suite of executive benefits, which may include:

Comprehensive medical, dental, and vision coverage
401(k) or retirement plans with employer contributions
Executive wellness and travel benefits
Annual professional development budgets
Executive disability and life insurance
Flexible work arrangements
Paid memberships in scientific or professional organizations

6. Signing Bonuses & Relocation Assistance

To attract elite medical leadership, companies may offer signing bonuses or relocation packages, particularly for executives moving to or within the Greater Boston/Cambridge biotech hub. These incentives generally range from $25,000 to $150,000, depending on experience and market competitiveness.

Total Compensation Potential

When combining base salary, bonuses, LTIPs, equity value, and additional incentives, the total annual compensation for a Chief Medical Officer in the rare disease biotech sector can range from $600,000 to several million dollars, especially in companies approaching late-stage clinical development or commercialization.

How to Apply

If you are an accomplished medical leader with deep experience in clinical development and a passion for advancing transformative therapies in rare diseases, we invite you to apply for the Chief Medical Officer (CMO) – Rare Disease Biotech position based in Cambridge, MA. This is a remarkable opportunity to guide clinical strategy, shape breakthrough programs, and drive meaningful impact for patients with unmet medical needs.

To apply, please submit your resume and a cover letter detailing your expertise in rare disease clinical development, regulatory strategy, clinical trial leadership, patient safety oversight, and cross-functional R&D collaboration. Highlight your experience advancing therapies through clinical stages, interacting with global regulatory bodies, and leading high-performing clinical teams.

This role offers a high-impact opportunity to shape the future of a growing biotech organization, champion innovative science, and lead clinical programs with life-changing potential. Apply today to take the next step in your executive career as a Chief Medical Officer (CMO) – Rare Disease Biotech in Cambridge, MA.

For more information or to explore similar opportunities, visit our Rare Disease Pharma Executive Search Firm Page.

Job Category: Rare Disease Pharma

Job Type: Full Time

Job Location: Cambridge

Chief Medical Officer – Rare Disease Biotech – Cambridge, MA